The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / Apr / Tuberculosis Screening Accuracy Boosted
Microbiology & Immunology Screening and monitoring Research and Innovations

Tuberculosis Screening Accuracy Boosted

Modelling reveals diagnostic advantage of immunological testing in TB screening in migrants

04/30/2025 News 1 min read
  • Full Article
  • Summary
  • Poll

Share

Objective:

To assess the accuracy of tuberculosis (TB) diagnostic strategies for migrant populations and the integration of TB infection tests into screening pathways.

Approach:
  • Study Design: Evaluation of 18 TB diagnostic tests across 437 studies, synthesizing data from 32 systematic reviews.
  • Metrics Assessed: Focus on test sensitivity, specificity, and diagnostic odds ratios (dORs) to evaluate diagnostic performance.
Key Findings:
  • Including interferon gamma release assay (IGRA) tests alongside traditional methods improved screening performance.
  • Three-test combinations generally outperformed two-test strategies.
  • Tests involving IGRAs as an initial screening step followed by chest X-ray and molecular assays yielded the highest dORs and positive predictive values.
  • Parallel symptom/chest X-ray screening followed by molecular confirmation achieved top sensitivity scores.
Interpretation:

Limitations:
  • Implementation may depend on local logistics and cost considerations.
Conclusion:

Sources:
  • European Respiratory Journal

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.